Evolus (EOLS) Return on Capital Employed Growth (1y) (2019 - 2026)
Evolus (EOLS) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.63 Bn | 30.69 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 1,195.00 |
| 10 | Evolus | 400.57 Mn | 350.78 Mn | 48.90 Mn | 871.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 871.00 |
| Dec 31, 2025 | -173.00 |
| Sep 30, 2025 | -110.00 |
| Jun 30, 2025 | -543.00 |
| Mar 31, 2025 | 429.00 |
| Dec 31, 2024 | 1,735.00 |
| Sep 30, 2024 | 1,888.00 |
| Jun 30, 2024 | 2,318.00 |
| Mar 31, 2024 | 1,953.00 |
| Dec 31, 2023 | 924.00 |
| Sep 30, 2023 | 559.00 |
| Jun 30, 2023 | -17.00 |
| Mar 31, 2023 | -1,400.00 |
| Dec 31, 2022 | -2,220.00 |
| Sep 30, 2022 | 3,772.00 |
| Jun 30, 2022 | 6,650.00 |
| Mar 31, 2022 | 9,946.00 |
| Dec 31, 2021 | 45,088.00 |
| Sep 30, 2021 | -5,610.00 |
| Jun 30, 2021 | -7,151.00 |